Literature DB >> 12135423

Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction.

C Sylvester-Hvid1, N Kristensen, T Blicher, H Ferré, S L Lauemøller, X A Wolf, K Lamberth, M H Nissen, L Ø Pedersen, S Buus.   

Abstract

Many different assays for measuring peptide-MHC interactions have been suggested over the years. Yet, there is no generally accepted standard method available. We have recently generated preoxidized recombinant MHC class I molecules (MHC-I) which can be purified to homogeneity under denaturing conditions (i.e., in the absence of any contaminating peptides). Such denatured MHC-I molecules are functional equivalents of "empty molecules". When diluted into aqueous buffer containing beta-2 microglobulin (beta2m) and the appropriate peptide, they fold rapidly and efficiently in an entirely peptide dependent manner. Here, we exploit the availability of these molecules to generate a quantitative ELISA-based assay capable of measuring the affinity of the interaction between peptide and MHC-I. This assay is simple and sensitive, and one can easily envisage that the necessary reagents, standards and protocols could be made generally available to the scientific community.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135423     DOI: 10.1034/j.1399-0039.2002.590402.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  44 in total

1.  Purification of correctly oxidized MHC class I heavy-chain molecules under denaturing conditions: a novel strategy exploiting disulfide assisted protein folding.

Authors:  Henrik Ferré; Emmanuel Ruffet; Thomas Blicher; Christina Sylvester-Hvid; Lise Lotte B Nielsen; Timothy J Hobley; Owen R T Thomas; Søren Buus
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

2.  Definition of supertypes for HLA molecules using clustering of specificity matrices.

Authors:  Ole Lund; Morten Nielsen; Can Kesmir; Anders Gorm Petersen; Claus Lundegaard; Peder Worning; Christina Sylvester-Hvid; Kasper Lamberth; Gustav Røder; Sune Justesen; Søren Buus; Søren Brunak
Journal:  Immunogenetics       Date:  2004-02-13       Impact factor: 2.846

Review 3.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

4.  Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.

Authors:  Arnold H Bakker; Rieuwert Hoppes; Carsten Linnemann; Mireille Toebes; Boris Rodenko; Celia R Berkers; Sine Reker Hadrup; Wim J E van Esch; Mirjam H M Heemskerk; Huib Ovaa; Ton N M Schumacher
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

5.  Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV.

Authors:  Anne S De Groot; Daniel S Rivera; Julie A McMurry; Soren Buus; William Martin
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

6.  High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination.

Authors:  M Wang; S T Tang; O Lund; M H Dziegiel; S Buus; M H Claesson
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

7.  Recombinant chymosin used for exact and complete removal of a prochymosin derived fusion tag releasing intact native target protein.

Authors:  Sune F L Justesen; Kasper Lamberth; Lise-Lotte B Nielsen; Claus Schafer-Nielsen; Søren Buus
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

8.  Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.

Authors:  Stefan Tenzer; Edmund Wee; Anne Burgevin; Guillaume Stewart-Jones; Lone Friis; Kasper Lamberth; Chih-hao Chang; Mikkel Harndahl; Mirjana Weimershaus; Jan Gerstoft; Nadja Akkad; Paul Klenerman; Lars Fugger; E Yvonne Jones; Andrew J McMichael; Søren Buus; Hansjörg Schild; Peter van Endert; Astrid K N Iversen
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

9.  Prediction of epitopes using neural network based methods.

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  J Immunol Methods       Date:  2010-10-31       Impact factor: 2.303

10.  The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype.

Authors:  Kasper Lamberth; Gustav Røder; Mikkel Harndahl; Morten Nielsen; Claus Lundegaard; Claus Schafer-Nielsen; Ole Lund; Soren Buus
Journal:  Immunogenetics       Date:  2008-09-04       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.